Microfluidic-assisted preparation of ARV 825 and Osimertinib loaded liposomal formulation as a potential system for colorectal cancer therapy.

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths globally. Current treatments, including surgery, chemotherapy, and radiotherapy, are often limited by significant off-target toxicity and drug resistance. Overexpressio…

Preview only. Read the full abstract at the source